Invariant natural killer T (iNKT) cells are a distinct population of lymphocytes characterized by their reactivity to glycolipids presented by CD1d. iNKT cells are found throughout the body, and little is known about their tissue-specific metabolic regulation. Here, we show that splenic and hepatic iNKT cells are metabolically comparable and rely on glycolytic metabolism to support their activation. Deletion of the pyruvate kinase M2 (Pkm2) gene in splenic and hepatic iNKT cells impairs their response to specific stimulation and their ability to mitigate acute liver injury. In contrast, adipose tissue (AT) iNKT cells exhibit a distinctive immunometabolic profile, with AMP-activated protein kinase (AMPK) being necessary for their function. AMPK deficiency impairs AT-iNKT physiology, blocking their capacity to maintain AT homeostasis and their ability to regulate AT inflammation during obesity. Our work deepens our understanding on the tissue-specific immunometabolic regulation of iNKT cells, which directly impacts the course of liver injury and obesity-induced inflammation.
Pubmed ID: 36848232 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD36
View all literature mentionsThis polyclonal targets Human GLUT1
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-4
View all literature mentionsThis monoclonal targets IL-12/IL-23 p40
View all literature mentionsThis monoclonal targets IL-1 beta (Pro-form)
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis monoclonal targets Ly-6C
View all literature mentionsThis monoclonal targets CD301
View all literature mentionsThis monoclonal targets CD206
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets Rat CD45 V500 Clone 30-F11
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsMus musculus with name B6;129S-Gt(ROSA)26Sortm1(CAG-COX8A/Dendra2)Dcc/J from IMSR.
View all literature mentionsMus musculus with name STOCK Prkaa1tm1.1Sjm/J from IMSR.
View all literature mentionsMus musculus with name B6;129S-Pkmtm1.1Mgvh/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ from IMSR.
View all literature mentions